30th mai 2024 Curium annonce les premieres doses commerciales en France de PYLCLARI® – un traceur PET innovant 18F-PSMA indique dans le cancer de la prostate
8th avril 2024 Curium plans to significantly expand Lutetium-177 capacity and PET footprint with agreement to acquire Eczacibaşi-Monrol